Management of severe dengue hemorrhagic fever and bleeding complications in a primigravida patient: A case report

被引:7
作者
Hariyanto H. [1 ]
Yahya C.Q. [2 ]
Wibowo P. [1 ]
Tampubolon O.E. [1 ]
机构
[1] Department of Anesthesiology and Critical Care Medicine, Siloam Hospitals Lippo Village, Jalan Siloam No. 6, Karawaci, Tangerang, Banten
[2] Department of Anesthesiology, Universitas Pelita Harapan Faculty of Medicine, Jalan Boulevard Jendral Sudirman, Lippo Karawaci, Tangerang
关键词
Bleeding; Case report; Dengue hemorrhagic fever; Pregnancy; Transfusions;
D O I
10.1186/s13256-016-1129-7
中图分类号
学科分类号
摘要
Background: The incidence of dengue hemorrhagic fever is increasing among the adult population living in endemic areas. The disease carries a 0.73% fatality rate for the general population, but what happens when the disease strikes a special subpopulation group, the obstetrics? Perhaps the important question specific to this special subpopulation revolves around the right time and mode of delivery under severe coagulopathy and plasma leakage in conditions of imminent delivery. Case presentation: A 24-year-old primigravid Sundanese woman presented to our intensive care unit due to acute pulmonary edema secondary to massive plasma leakage caused by severe dengue. She tested positive for both immunoglobulin G and immunoglobulin M dengue serology indicating she had secondary dengue infection, which placed her at risk for an exaggerated cytokine response as was evident clinically. She had to undergo an emergency cesarean section which was later complicated by rebleeding and hemodynamic instability due to an atypical defervescence period. She was successfully managed by multiple blood transfusions and was discharged from our intensive care unit on day 8 without any negative sequel. Conclusions: Fever, thrombocytopenia, and hemoconcentration are the classical symptoms of dengue hemorrhagic fever observed in adult, pediatric, and obstetric populations. However, a clinician must be particularly watchful in treating a pregnant dengue-infected patient as physiologic hematology changes provide greater volume compensation and the advent of shock marks significant volume loss. In conclusion, an important principle in the management of dengue hemorrhagic fever in pregnancy is to prioritize maternal well-being prior to addressing fetal issues. © 2016 The Author(s).
引用
收藏
相关论文
共 14 条
[1]  
Karyanti M.R., Uiterwaal C.S.P.M., Kusriastuti R., Hadinegoro S.R., Rovers M.M., Heesterbeek H., Et al., The changing incidence of Dengue Haemorrhagic Fever in Indonesia: A 45-year registry-based analysis, BMC Infect Dis, 14, 1, pp. 1-7, (2014)
[2]  
Chitra T.V., Panicker S., Maternal and fetal outcome of dengue fever in pregnancy, J Vector Borne Dis, 48, 4, pp. 210-213, (2011)
[3]  
Trikha A., Singh P.M., The critically ill obstetric patient - Recent concepts, Indian J Anaesth, 54, 5, pp. 421-427, (2010)
[4]  
Costantine M.M., Physiologic and pharmacokinetic changes in pregnancy, Front Pharmacol, 5, (2014)
[5]  
Martina B.E.E., Koraka P., Osterhaus A.D.M.E., Dengue virus pathogenesis: An integrated view, Clin Microbiol Rev, 22, 4, pp. 564-581, (2009)
[6]  
Sellahewa K.H., Pathogenesis of dengue haemorrhagic fever and its impact on case management, ISRN Infect Dis, 2013, (2013)
[7]  
Nachman R.L., Rafii S., Platelets, petechiae, and preservation of the vascular wall, N Engl J Med, 359, 12, pp. 1261-1270, (2008)
[8]  
Kaufman R.M., Djulbegovic B., Gernsheimer T., Kleinman S., Tinmouth A.T., Capocelli K.E., Et al., Platelet transfusion: A clinical practice guideline from the AABB, Ann Intern Med, 162, 3, pp. 205-213, (2015)
[9]  
Carson J.L., Grossman B.J., Kleinman S., Tinmouth A.T., Marques M.B., Fung M.K., Et al., Red blood cell transfusion: A clinical practice guideline from the AABB, Ann Intern Med, 157, 1, pp. 49-58, (2012)
[10]  
Rollins M., Lucero J., Overview of anesthetic considerations for Cesarean delivery, Br Med Bull, 101, 1, pp. 105-125, (2012)